Researchers
have developed a new drug that is effective against non-severe cases of
malaria, according to results from an FDA-supervised clinical trial. The
results are significant as public health experts have long warned that the
parasite responsible for most malaria cases, Plasmodium falciparum, is
developing resistance to widely used treatments. New medications are needed to
build up secondary defenses against drug-resistant strains of the parasite.
The
results are significant as public health experts have long warned that the
parasite responsible for most malaria cases, Plasmodium falciparum, is
developing resistance to widely used treatments. New medications are needed to
build up secondary defenses against drug-resistant strains of the parasite.
"The
clinical trial results are extraordinarily encouraging," said Dr. Donald
Krogstad, senior author and professor of tropical medicine at Tulane University
School of Public Health and Tropical Medicine. "Compared to the current
first-line recommendation for treatment of malaria, the new drug comes out very
well."
See:
Posted by Dr. Tim Sandle
No comments:
Post a comment
Pharmaceutical Microbiology Resources